Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database
Leukemia · 2024
DOI: 10.1038/s41375-024-02413-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia, 2024. Verfasst von Joachim Alexandre und 9 weiteren Autor:innen. Beteiligte Einrichtung: Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France. joachim.alexandre@unica…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Adenine, Pharmacovigilance, Piperidines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France. joachim.alexandre@unicaen.fr.
- Caen-Normandy University Hospital, PICARO Cardio-Oncology Program, Department of Pharmacology, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France. joachim.alexandre@unicaen.fr.
- Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France.
- Caen-Normandy University Hospital, Department of Cardiology, Avenue de la Côte de Nacre, F-14000, Caen, France.
- Caen-Normandy University Hospital, PICARO Cardio-Oncology Program, Departments of Pharmacology and Medical Oncology, Avenue de la Côte de Nacre, F-14000, Caen, France.
- Caen-Normandy University Hospital, Hematology Institute, Avenue de la Côte de Nacre, F-14000, Caen, France.
ORCID-Profile: Joachim Alexandre, Ghandi Damaj, Damien Legallois, Charles Dolladille
Zitieren
APA
Alexandre, J., Font, J., Angélique, D. S., Delapierre, B., Damaj, G., Plane, A. F., Legallois, D., Milliez, P., Dolladille, C., & Chrétien, B. (2024). Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database. Leukemia. https://doi.org/10.1038/s41375-024-02413-5
Vancouver
Alexandre J, Font J, Angélique DS, Delapierre B, Damaj G, Plane AF, et al. Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database. Leukemia. 2024. doi:10.1038/s41375-024-02413-5
BibTeX
@article{Alexandre2024,
author = {Alexandre, Joachim and Font, Jonaz and Angélique, Da-Silva and Delapierre, Baptiste and Damaj, Ghandi and Plane, Anne-Flore and Legallois, Damien and Milliez, Paul and Dolladille, Charles and Chrétien, Basile},
title = {Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database},
journal = {Leukemia},
year = {2024},
doi = {10.1038/s41375-024-02413-5}
}
EUVIMED